Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bally

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
Biochemistry|September 14, 1982
Influence of cholesterol on the structural preferences of dioleoylphosphatidylethanolamine-dioleoylphosphatidylcholine systems: a phosphorus-31 and deuterium nuclear magnetic resonance studyC P Tilcock, M B Bally, S B Farren, et al.
Thrombosis and Haemostasis|December 22, 1988
Interactions of liposomes and plateletsL W Reinish, M B Bally, H C Loughrey, et al.
Biochimica Et Biophysica Acta|September 13, 1995
The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug deliveryM S Webb, J J Wheeler, M B Bally, et al.
Pharmaceutical Research|November 7, 2006
A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft modelSebastian Cogswell, Stuart Berger, Dawn Waterhouse, et al.
Journal of Immunological Methods|August 28, 1990
Optimized procedures for the coupling of proteins to liposomesH C Loughrey, L S Choi, P R Cullis, et al.
Pharmaceutical Research|October 31, 2001
Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugsD N Waterhouse, N Dos Santos, L D Mayer, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 18, 2002
Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapyEmma S Guns, Tetyana Denyssevych, Ross Dixon, et al.
Transplantation|November 15, 1995
Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistributionE Choice, D Masin, M B Bally, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomesN L Boman, V A Tron, M B Bally, et al.
Investigational New Drugs|May 23, 2012
Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancerNilesh A Patankar, Dawn Waterhouse, Dita Strutt, et al.
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
Biochemistry|September 14, 1982
Influence of cholesterol on the structural preferences of dioleoylphosphatidylethanolamine-dioleoylphosphatidylcholine systems: a phosphorus-31 and deuterium nuclear magnetic resonance studyC P Tilcock, M B Bally, S B Farren, et al.
Thrombosis and Haemostasis|December 22, 1988
Interactions of liposomes and plateletsL W Reinish, M B Bally, H C Loughrey, et al.
Biochimica Et Biophysica Acta|September 13, 1995
The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug deliveryM S Webb, J J Wheeler, M B Bally, et al.
Pharmaceutical Research|November 7, 2006
A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft modelSebastian Cogswell, Stuart Berger, Dawn Waterhouse, et al.
Journal of Immunological Methods|August 28, 1990
Optimized procedures for the coupling of proteins to liposomesH C Loughrey, L S Choi, P R Cullis, et al.
Pharmaceutical Research|October 31, 2001
Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugsD N Waterhouse, N Dos Santos, L D Mayer, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 18, 2002
Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapyEmma S Guns, Tetyana Denyssevych, Ross Dixon, et al.
Transplantation|November 15, 1995
Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistributionE Choice, D Masin, M B Bally, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomesN L Boman, V A Tron, M B Bally, et al.
Investigational New Drugs|May 23, 2012
Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancerNilesh A Patankar, Dawn Waterhouse, Dita Strutt, et al.
Pageof 23